Granules India has unveiled its Mobile Cancer Screening Unit at AIG Hospitals. This initiative, spearheaded by the Granules Trust in partnership with Asian Medical Foundation, UC Breast Foundation and AIG Hospitals aims to enhance cancer detection and treatment in underserved communities.
The state-of-the-art mobile unit ‘Breast Health Express,’ brings advanced medical technology directly to communities in need. Equipped with cutting-edge mammography and ultrasound capabilities, as well as facilities for essential health checks such as haemoglobin, blood pressure, and glucose levels, this mobile clinic marks a major advancement in equitable and accessible healthcare. By offering these critical services and free medicine distribution, the initiative seeks to revolutionize cancer screening, with a particular emphasis on early breast cancer detection.
Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1618.50 |
| Dr. Reddys Lab | 1312.40 |
| Cipla | 1295.00 |
| Zydus Lifesciences | 930.00 |
| Lupin | 2285.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: